{"nct_id":"NCT02201316","title":"A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting Conditions","status":"COMPLETED","status_verified_date":"2017-05","start_date":"2014-02-03","start_date_type":"ACTUAL","primary_completion_date":"2014-03-18","primary_completion_date_type":"ACTUAL","completion_date":"2014-03-18","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}